Elevance Health Quarterly Cash Flow Statement
NYSE: ELVHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Elevance Health free cash flow
In the quarter ended Jun 30, 2026, Elevance Health generated $1.91 billion of operating cash flow and spent $287.0 million on capital expenditures. That left free cash flow of $1.63 billion, a free-cash-flow margin of 3.2% of revenue. Free cash flow was down 9.0% from the prior year's $1.79 billion.
Elevance Health returned $607.0 million to shareholders: $373.0 million in dividends and $234.0 million in share repurchases, equal to 37% of free cash flow. Free cash flow covered dividend payments 4.4 times.
Summary generated from market data by MetaCap's automated system. Methodology
Elevance Health cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.45B | 1.76B | 546.00M | 1.19B | 1.74B | 2.18B | 413.00M | 1.01B | 2.30B | 2.25B | 831.00M | 1.30B |
| Net Income growth (YoY) | -16.63% | -19.41% | +32.20% | +17.76% | -24.21% | -2.89% | -50.30% | -22.46% | +23.98% | +12.23% | -5.25% | -18.65% |
| Depreciation & Amortization | 366.00M | 354.00M | 406.00M | 387.00M | 380.00M | 373.00M | 398.00M | 231.00M | 0 | 331.00M | 424.00M | 220.00M |
| Stock-Based Compensation | 75.00M | 55.00M | 30.00M | 84.00M | 81.00M | 81.00M | -29.00M | 66.00M | 92.00M | 62.00M | 72.00M | 78.00M |
| Change in Working Capital | -665.00M | -2.46B | 878.00M | 1.29B | -959.00M | -3.69B | 1.06B | 972.00M | -690.00M | -1.31B | -3.70B | -961.00M |
| Operating Cash Flow | 1.91B | 4.33B | 84.00M | 1.14B | 2.05B | 1.02B | 706.00M | 2.68B | 447.00M | 1.98B | -2.97B | 2.61B |
| Capital Expenditures | -287.00M | -235.00M | -293.00M | -360.00M | -267.00M | -196.00M | -322.00M | -332.00M | -323.00M | -279.00M | -326.00M | -319.00M |
| Investing Cash Flow | 159.00M | -1.64B | 464.00M | -1.22B | -687.00M | 103.00M | -1.64B | -401.00M | -818.00M | -2.31B | -1.03B | -687.00M |
| Dividends Paid | -373.00M | -376.00M | -377.00M | -376.00M | -385.00M | -386.00M | -373.00M | -386.00M | -378.00M | -379.00M | -346.00M | -348.00M |
| Share Repurchases | -234.00M | -1.12B | -471.00M | -876.00M | -378.00M | -880.00M | -1.81B | -60.00M | -463.00M | -566.00M | -928.00M | -480.00M |
| Debt Issued | — | — | -3.00M | 2.99B | — | — | 5.13B | 0 | 2.58B | 0 | 0 | 0 |
| Debt Repaid | 0 | -750.00M | 3.00M | -900.00M | 0 | -1.25B | -850.00M | -800.00M | 0 | 0 | -1.00M | 0 |
| Financing Cash Flow | -1.49B | -2.52B | 236.00M | 243.00M | -308.00M | -1.91B | 1.41B | -915.00M | 668.00M | 32.00M | -394.00M | -994.00M |
| Net Change in Cash | 575.00M | 166.00M | 778.00M | 153.00M | 1.06B | -788.00M | 468.00M | 1.37B | 292.00M | -300.00M | -4.39B | 928.00M |
| Free Cash Flow | 1.63B | 4.10B | -209.00M | 775.00M | 1.79B | 821.00M | 384.00M | 2.35B | 124.00M | 1.70B | -3.30B | 2.29B |
This table shows 12 quarterly periods of Elevance Health's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ELV's reporting calendar. What is a cash flow statement?